David Henson is a PhD candidate in the University of Kentucky, College of Pharmacy. He completed a double major in biology and chemistry at Hanover College before joining the UK’s MD-PhD program. At UK he works with Dr. Vincent Venditto to study how antibodies effect the development of cardiovascular disease and potential immunomodulatory strategies to improve patient outcomes.
The interplay between the immune system and the development of cardiovascular disease has been well established and our understanding of this connection continues to grow. My curiosity of how the immune system alters disease positions me at the nexus of these fields with significant translational impact. My current project has the potential to improve patient care through the discovery of novel immune biomarkers capable of predicting disease outcomes. Through this research, I will develop tools to identify patients at high risk for cardiovascular disease progression and explore novel strategies to modulate the immune system to improve clinical outcomes.
Pharmaceutical Sciences Excellence in Graduate Achievement Fellowship -2018 to 2019
TL-1 Grant from University of Kentucky Center for Clinical and Translational Science TL1TR001997 -2016 to 2018
Henson D., Chou C., Sakurai N., Egawa T. A Silencer-Proximal Intronic Region Is Required for Sustained CD4 Expression in Postselection Thymocytes. Journal of Immunology 192 4620-7. May, 2014.
Huaman M., Henson D., Ticona E., Sterling T., Garvy B. Tuberculosis and Cardiovascular Disease: Linking the Epidemics. Tropical Diseases, Travel Medicine and Vaccines 1:10. October, 2015.
Huaman M., Kryscio R., Fichtenbaum C., Henson D., Salt E., Garvy B. Tuberculosis and risk of Myocardial Infarction: a Propensity Score-Matched Analysis. Epidemiology and Infection 145:7 1363-1367. May, 2017
Huaman M., Ticona E., Miranda G., Kryscio R., Mugruza R. Aranda E. Rondan P. Henson D., Ticona C. Sterling T. Fichtenbaum C., Garvy B. The Relationship between Latent Tuberculosis Infection and Acute Myocardial Infarction. Clinical Infectious Disease. In revision.